Clinical Trials Logo

Insulin Resistance clinical trials

View clinical trials related to Insulin Resistance.

Filter by:

NCT ID: NCT00732485 Withdrawn - Burn Clinical Trials

Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate

Start date: August 2008
Phase: Phase 2/Phase 3
Study type: Interventional

Major burn injury causes significant insulin resistance on glucose and protein metabolism that persists for up to 6 months after the acute injury This project proposes to answer the following questions: 1. Will fenofibrate given to burn patients with insulin resistance restore their insulin sensitivity? 2. What is the relationship between mitochondrial dysfunction in muscle tissue as the causative mechanism of burn related insulin resistance? 3. To what extent will the restored insulin sensitivity affect glucose and protein metabolism in muscle, regenerating wounds and the liver, i.e. ameliorate burn related hyperglycemia and protein catabolism?

NCT ID: NCT00724282 Completed - Insulin Resistance Clinical Trials

Treatment of Insomnia and Glucose Metabolism

Start date: April 2008
Phase: Phase 4
Study type: Interventional

Available data suggest that obtaining adequate sleep is associated with a better ability of the body to use carbohydrates as a source of energy and a lower risk of developing diabetes. The sleeping pill, Eszopiclone (Lunesta), has been approved by the Food and Drug Administration for the treatment of people who complain of trouble falling or staying asleep. This study will examine the hypothesis that the use of Eszopiclone (Lunesta) to improve the sleep of people with insomnia may also improve the use of sugar in their body.

NCT ID: NCT00724087 Completed - Type 2 Diabetes Clinical Trials

Sleep Loss and Energy Metabolism in People With Family History of Type 2 Diabetes.

Start date: July 2008
Phase: N/A
Study type: Interventional

The use of energy from food changes when people sleep. However, it is still not known if differences in the amount of nighttime sleep have an effect on the amount of energy that people who have a relative with type 2 diabetes (parent, sibling, or grandparent) use to perform their daily activities. This study is being done to test the hypothesis that the daily use of energy in people who have a history of type 2 diabetes in their family will be different after they have slept short hours for 16 days in comparison to when they have slept longer hours for 16 days.

NCT ID: NCT00721019 Completed - Type 2 Diabetes Clinical Trials

Sleep Loss and Glucose Metabolism in People With Family History of Type 2 Diabetes.

Start date: July 2008
Phase: N/A
Study type: Interventional

The use of sugar and starch-like foods for energy (carbohydrate metabolism) changes when people sleep. However, it is still not known if differences in the amount of nighttime sleep have an effect on the carbohydrate metabolism of people who have a relative with type 2 diabetes (parent, sibling, or grandparent). This study is being done to test the hypothesis that the carbohydrate metabolism of people who have a history of type 2 diabetes in their family will be different after they have slept short hours for 10 days in comparison to when they have slept longer hours for 10 days.

NCT ID: NCT00720889 Completed - Type 2 Diabetes Clinical Trials

Glucose Metabolism and Sleep in People With Family History of Type 2 Diabetes.

Start date: July 2008
Phase: N/A
Study type: Observational

The use of sugar and starch-like foods for energy (carbohydrate metabolism) changes when people sleep. However, it is still not known if differences in the amount of nighttime sleep have an effect on the carbohydrate metabolism of people who have a relative with type 2 diabetes (parent, sibling, or grandparent). This study is being done to test the hypothesis that individual differences in habitual sleep duration may be related to differences in the carbohydrate metabolism of people who have a history of type 2 diabetes in their family.

NCT ID: NCT00707603 Completed - Hepatitis C Clinical Trials

Chronic Hepatitis C and Insulin Resistance

Start date: May 2006
Phase: N/A
Study type: Observational

Chronic hepatitis C (CHC) is among the commonest chronic infectious disease in Australia with >200,000 exposed persons. Amongst non-infectious chronic conditions- Type 2 diabetes, obesity and heart disease are extremely common. This study will examine the relationship between insulin resistance, fat deposition in the liver, muscle and abdomen, and liver injury due to CHC

NCT ID: NCT00705224 Completed - Clinical trials for Hepatitis C, Chronic

Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

Start date: May 2008
Phase: N/A
Study type: Observational

Naïve patients with chronic hepatitis C (CHC) of any genotype will be treated with a standard treatment regimen (pegylated interferon and ribavirin) according to routine clinical practice in Russia. The objective of this study is to examine the influence of insulin resistance on the safety and efficacy of treatment with pegylated interferon and ribavirin and to determine the prevalence of insulin resistance in different populations of CHC patients.

NCT ID: NCT00704912 Completed - Clinical trials for Polycystic Ovary Syndrome

Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women

OWL-PCOS
Start date: September 2008
Phase: Phase 2
Study type: Interventional

The goal of this three-armed randomized controlled trial is to establish the relative roles of treatment of hyperandrogenism versus obesity (as the largest modifiable factor contributing to insulin resistance) in treating infertility and improving pregnancy outcomes among obese PCOS women. The investigators hypothesize that the key to restoring ovulation leading to live birth is to correct hyperandrogenism with oral contraceptive pills, but the key to avoiding later pregnancy complications is to improve insulin sensitivity with weight loss.

NCT ID: NCT00704236 Completed - Type 2 Diabetes Clinical Trials

Improvement of Insulin Resistance With Traditional Chinese Treatment in Patients With Type 2 Diabetes

Start date: September 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy of Traditional Chinese Treatment(TCT) on insulin sensitivity and other related factors in type 2 diabetes by using an double-blind, randomized, parallel control and prospective study This traditional compound Chinese herb preparation is referred to this study, with three kinds of plants: 50 mg of Coptis Chinensis, 30 mg of Astragalus mambranesceus and 120 mg of Lonicera Japonica, all of which are selected by The Chinese Academy of Medical Sciences among those traditionally considered effective and safe in the treatment of diabetes. Patients enrolled were randomized into TCT group and placebo group administrated with TCT and placebo respectively. Glucose disposal rate (GDR), fasting plasma glucose (FPG), postprandial plasma glucose (PPG), HbA1C and other metabolic components were assessed at baseline and end point

NCT ID: NCT00700362 Withdrawn - Diabetes Mellitus Clinical Trials

Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)

Start date: December 2011
Phase:
Study type: Observational

Normoglycemia is important for the outcome of surgical and medical conditions. Insulin infusions have been studied to achieve normoglycemia during these circumstances and have proved to be useful. Insulin given by subcutaneous injections has longer duration compared to intravenous given insulin which makes it more difficult to control. The hypothesis behind the trial is the concept that insulin infusion is more effective in reaching normoglycemia in diabetic subjects during foot ulcer infection and surgical wound infection. - The study evaluates a target controlled insulin infusion or conventional therapy as antidiabetic treatment during foot ulcer infection and surgical wound infection. - Secondary efficacy parameter will be hospital stay, laboratories for inflammation and oxidative stress.